-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, BASF announced its second-quarter results-sales increased by 56% to 19.
8 billion euros; pre-interest and tax earnings excluding special items increased significantly to 2.
4 billion euros; cash flow from operating activities was 2.
5 billion Euros, an increase of 295 million Euros from the second quarter of last year
.
The company's outlook for 2021: sales are expected to be 74 billion to 77 billion euros; pre-interest and tax earnings excluding special items are expected to be 7 to 7.
According to Dr.
Martin Brudermüller, Chairman of the Executive Board of BASF Europe, the 56% increase in sales was mainly due to the increase in sales and prices in various business areas
.
The price level of surface treatment technology business, chemical business and material business has increased significantly
Earnings before interest and taxes excluding special items in the second quarter of 2021 increased by more than 2 billion euros compared with the second quarter of 2020
.
This is mainly due to the substantial increase in EBIT in the chemical business field and the material business field excluding special items
BASF expects stable industrial economic development in the second half of 2021
.
BASF's above forecast assumes that there will be no strict measures to control economic activities in response to the new crown pneumonia epidemic in the second half of 2021